Comparison Overview
High-Content Imaging & Analysis | Molecular Devices
High-Content Imaging & Analysis | Molecular Devices
N/A
Last Update: 22/07/2026
CSL
655 Elizabeth St, Melbourne, 3000, AU
Last Update: 02/04/2026
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916,...
Compliance Ranges Comparison
High-Content Imaging & Analysis | Molecular Devices
CSL
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for High-Content Imaging & Analysis | Molecular Devices in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for CSL in 2026.
Incident History - High-Content Imaging & Analysis | Molecular Devices (X = Date, Y = Severity)
High-Content Imaging & Analysis | Molecular Devices cyber incidents detection timeline including parent company and subsidiaries.
Incident History - CSL (X = Date, Y = Severity)
CSL cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
High-Content Imaging & Analysis | Molecular Devices
CSL
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.